SBRT Technique Implementation for Spinal Metastases Irradiation

Summary

Stereotactic body radiotherapy (SBRT) is a highly precise, image-guided radiotherapy technique delivering 1-5 high-dose fractions to spinal metastases. Compared with conventional radiotherapy, SBRT enables delivery of a higher biologically effective dose while maintaining high precision. The Institute of Oncology Ljubljana initiated spinal SBRT treatments in 2017 and introduced an institutional SBRT spine protocol in 2019. As SBRT is technically demanding, strict adherence to standardized planning and delivery procedures is essential to ensure treatment quality and patient safety. This clinical program aims to support structured implementation and continuous development of the institutional SBRT spine protocol in routine clinical practice. The study prospectively evaluates treatment-related toxicity and local tumor control following SBRT for spinal metastases in order to monitor treatment safety and effectiveness within the institutional program.

Eligibility

Inclusion Criteria:

* Adult patients (≥18 years) with spinal metastases or spinal tumors referred for stereotactic body radiotherapy (SBRT).
* Patients eligible for SBRT treatment according to the institutional SBRT spine protocol.
* Ability to undergo CT simulation, immobilization, and image-guided radiotherapy procedures.

Exclusion Criteria:

* Inability to tolerate SBRT positioning or immobilization.
* Clinical situations requiring urgent surgical intervention or alternative treatment.
* Other medical conditions that prevent safe SBRT delivery.

Conditions4

Browse More Trials